Patents by Inventor Andrew John Hutton

Andrew John Hutton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240197875
    Abstract: The invention relates to methods for expanding ?? T cells comprising preparing a composition enriched for ?? T cells and culturing the composition in the presence of feeder cells. Also provided is a method for engineering ?? T cells comprising preparing a composition enriched for ?? T cells, transducing the composition to express a chimeric antigen receptor (CAR) specific for a tumour associated antigen and culturing the transduced composition to expand the engineered ?? T cells. Also provided are expanded and engineered ?? T cells produced according to the described methods, which find utility in adoptive T cell therapies, chimeric receptor therapies and the like.
    Type: Application
    Filed: April 8, 2022
    Publication date: June 20, 2024
    Applicant: GAMMADELTA THERAPEUTICS LIMITED
    Inventors: Andrew John HUTTON, Istvan KOVACS, Oliver NUSSBAUMER
  • Publication number: 20240082308
    Abstract: The invention relates to methods of treating myeloid malignancies by administering compositions comprising V?1+ T cells.
    Type: Application
    Filed: September 21, 2023
    Publication date: March 14, 2024
    Applicant: GammaDelta Therapeutics Ltd
    Inventors: Andre Goncalo Do Espirito Santo SIMOES, Biagio Di LORENZO, Michael KOSLOWSKI, Bruno Miguel De Carvalho E SILVA SANTOS, Andrew John HUTTON, Timothy Joel RECALDIN, Daniel FOWLER, Alice BROMLEY, Oliver NUSSBAUMER
  • Publication number: 20230149459
    Abstract: The invention relates to compositions comprising V?1+ T cells, for use in treating myeloid malignancies. The present invention also relates to methods of treatment using said compositions.
    Type: Application
    Filed: March 20, 2020
    Publication date: May 18, 2023
    Applicant: GammaDelta Therapeutics Limited
    Inventors: Andre Goncalo do Espirito Santo SIMOES, Biagio DI LORENZO, Michael KOSLOWSKI, Bruno Miguel de Carvalho e SILVA-SANTOS, Andrew John HUTTON, Timothy Joel RECALDIN, Daniel FOWLER, Alice BROMLEY, Oliver NUSSBAUMER
  • Publication number: 20210290674
    Abstract: The invention relates to methods of treating myeloid malignancies by administering compositions comprising V?1+T cells.
    Type: Application
    Filed: March 19, 2021
    Publication date: September 23, 2021
    Inventors: Andre Goncalo Do Espirito Santo SIMOES, Biagio Di Lorenzo, Michael Koslowski, Bruno Miguel De Carvalho E. Silva Santos, Andrew John Hutton, Timothy Joel Recaldin, Daniel Fowler, Alice Bromley, Oliver Nussbaumer